Atlanta startup OncoLens raises $7.25M to expand its cancer treatment platform

Atlanta-based health technology startup OncoLens raised a $7.25 million Series A round to increase its platform and hire more employees.   Atlanta’s BIP Capital, Martin Ventures and SeedToB participated in the round, according to a press release. The Series A brings the startup’s total investments to $8 million.   CEO and co-founder Anju Mathew said the new capital will fuel the company’s rapid growth in the cancer treatment space. OncoLens provides a care treatment planning…

Atlanta-based health technology startup OncoLens raised a $7.25 million Series A round to increase its platform and hire more employees.   Atlanta’s BIP Capital, Martin Ventures and SeedToB participated in the round, according to a press release. The Series A brings the startup’s total investments to $8 million.   CEO and co-founder Anju Mathew said the new capital will fuel the company’s rapid growth in the cancer treatment space. OncoLens provides a care treatment planning…

View Original Article Source